// App-Quantinova.ai

2295 : A Mechanism For Switch Of Integrin Signaling Direction and a New Anti-Thrombotic Strategy Through Selective Outside-In Signaling Inhibition

Researchers

Presenter

  • Bo Shen

Principal Investigators

  • Xiaojuan Zhao

  • Kelly A -Brien

  • Aleksandra Stojanovic-Terpo

  • Michael Keegan Delaney

  • Kyungho Kim

  • Jaehyung Cho

  • Stephen C.-T Lam

  • Xiaoping Du

Medical Centers

  • Department of Pharmacy Practice, University of Illinois at Chicago, Chicago, IL

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

Disease

  • Venous thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • Hemostatic Solution

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved